Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

WHO Recommends Against GLP-1s For Young Kids—Amid Wegovy Trial For 6 Year Olds

Despite a nearly 600% surge in adolescent GLP-1 prescriptions, the WHO says they may pose critical safety risks to growing bodies.

WHO Recommends Against GLP-1s For Young Kids—Amid Wegovy Trial For 6 Year Olds

We haven't written up this one. Forbes has the full story — the link below goes straight to it.

Read the original at forbes.com →

Report a problem with this story

More in Health & Medicine

More from Wednesday 7 October →